| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $424.2M | — | +14.5% |
| Cost of Revenue | $73.8M | — | +12.4% |
| Gross Profit | $350.4M | — | +14.9% |
| R&D Expense | $83.0M | — | +14.6% |
| SG&A Expense | $58.5M | — | +23.9% |
| Operating Income | $126.3M | — | +9.6% |
| Interest Expense | $7.5M | — | +208.0% |
| Pre-tax Income | $118.6M | — | +6.0% |
| Income Tax | $23.2M | — | +13.0% |
| Net Income | $95.4M | — | +4.4% |
| EPS (Basic) | $0.31 | — | +6.9% |
| EPS (Diluted) | $0.30 | — | +7.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $105.2M | -14.7% | +25.7% |
| Current Assets | $518.2M | -3.9% | +16.2% |
| Total Assets | $3.52B | -0.9% | +3.5% |
| Current Liabilities | $1.01B | +4.9% | +11.1% |
| Long-term Debt | $1.12B | -10.7% | -10.4% |
| Total Liabilities | $2.30B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $193.4M | — | -11.9% |
| Capital Expenditures | $5.6M | — | +82.4% |
| Investing Cash Flow | -$5.6M | — | -82.4% |
| Financing Cash Flow | -$204.4M | — | -1.8% |
| Free Cash Flow | $187.9M | — | -13.2% |
| -0.3% |
| Stockholders' Equity | $1.23B | +3.1% | +11.7% |